EAM
GRCL

Exome Asset Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Exome Asset Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,974
Closed -$411K – 77
2023
Q4 		$411K Buy
+40,974
New +$411K 0.41% 49